Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of neurological disorders
3.2.1.2 Advancement in biomarker research
3.2.1.3 Adoption of personalized medicine
3.2.1.4 Rising awareness among patients and healthcare providers of neurological disorders
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of biomarker testing
3.2.2.2 Lack of standardization
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Proteomic biomarkers
5.3 Genomic biomarkers
5.4 Metabolomic biomarkers
5.5 Imaging
5.6 Other biomarker types
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Alzheimer’s disease
6.3 Parkinson’s disease
6.4 Autism spectrum disorders
6.5 Epilepsy
6.6 Other diseases
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Hospitals and clinics
7.3 Research laboratories
7.4 Biopharmaceutical companies
7.5 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 ACOBIOM
9.3 Alseres Pharmaceuticals
9.4 Banyan Biomarkers
9.5 Bio-Rad Laboratories
9.6 DiaGenic ASA
9.7 Johnson & Johnson Services
9.8 Merck KGaA
9.9 QIAGEN
9.10 Quanterix
9.11 Rules-Based Medicine
9.12 Thermo Fisher Scientific
